Pharmacy Technician Pulse

WuXi and BIO’s grip-and-grin

STAT

APRIL 18, 2024

Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. China tension tests new BIO CEO When John Crowley took over as BIO’s CEO, all was fine and dandy with WuXi AppTec, which was then a member of the trade group.

Unified vision essential in UK advanced manufacturing

European Pharmaceutical Review

NOVEMBER 14, 2023

This ‘manifesto for growth’, developed by the Manufacturing Five (M5), a coalition of the UK’s leading advanced trade associations, proposed the reforms necessary for the UK to close the gap with global competitors and growth of innovative manufacturing in the country. Article: Are we globally prepared for the next pandemic?

US frets over pharma supply chain security

pharmaphorum

JUNE 22, 2022

Ben Hargreaves finds out how the issue of foreign manufacturing has become a major US political talking point and how this could influence the pressures facing the industry. In recent years, this has become a major talking point within US politics. Security of supply.

Generic Medicine

Generic Medicine FDA Vaccines

Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention

ISPE

MAY 22, 2023

Lisa mentioned that there had been some trade restrictions with some LMICs withholding drug products and active pharmaceutical ingredients (APIs). Amgen had a policy of not allowing drug shortage. Disclaimer This article contains an abridged, unofficial summary of presentations and discussion during a virtual event on 9 February 2023.

Communication

Communication FDA

Innovation and collaboration – the MHRA’s pandemic approach

pharmaphorum

NOVEMBER 24, 2021

The pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, from clinical trial recruitment to the journey required for medicines or vaccines to reach patients. The Government has committed to relooking at regulation as it determines its own independent trading policy.

Vaccines

Vaccines Documentation

Sentiment towards Brexit has worsened three years after UK left EU

Pharmaceutical Technology

MAY 31, 2023

Policy and measurements had been established to minimise the negative influence of Brexit such as the EU–UK Trade and Cooperation Agreement (TCA), UK Medicines and Medical Devices Act, and the extended Horizon Europe Guarantee scheme to provide support to Horizon Europe applicants from the UK.

Frost renews call to exclude medicines from Northern Ireland Brexit rules

The Guardian - Pharmaceutical Industry

JANUARY 19, 2023

Industry figures warn of supply ‘cliff edge’ when new regulations come into effect in December 2023 Lord Frost has renewed calls for medicines to be excluded from the Brexit trading rules in Northern Ireland amid claims that supplies could be threatened in December when regulation of pharmaceuticals in the UK further diverges from the EU.

Twenty Women Leaders In Healthcare Industry

PharmaShots

MARCH 9, 2023

Schaeffer Center for Health Policy and Economics at the University of Southern California and the Leadership Consortium of the National Academy of Medicine. Other Affiliations: Jennifer is the Board of Directors member in Pharmaceutical Research and Manufacturers of America. She also sits on the Advisory Board of the Leonard D.

FDA

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization

Contamination Trends & Proposed Solutions

ISPE

MARCH 8, 2023

These are most notably observable in terms of the activities carried out by the US FDA, ranging from the need to announce inspections in advance, which gives time for manufacturers to rectify any issues, 50 to staffing issues that affect inspection capacity and restrictive policies. 52 Other RAs face similar staffing and labor issues.

Compounding

Compounding Compounding Pharmacies Packaging FDA

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

DECEMBER 9, 2022

Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. In emerging markets around the world, regulatory, economic, and political barriers can impede the availability of certain pharmaceuticals, supplements, and diagnostics.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Communication

Economic Theory Explains Big Pharma Scare Tactics on Importation

Policy Prescription

OCTOBER 3, 2023

Consider how this international drug price dynamic may affect the politics of the issue. In the summer of 2022, a policy debate in the Senate HELP committee ensued with Sens. However, it makes sense that regulatory reforms to expressly permit personal imports or legalize commercial imports would be based on trade between the U.S.,

FDA

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

JUNE 8, 2020

Dave (HR): Well to me, you know again this real market, people are getting great care and great outcomes and the physicians, surgery centers and so on are very happy and thriving economically and so there’s a fair trade if you will, between the two parties in the kind of this rigged sort of PPO market.

Health and Personal Care Stores

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies